TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

M Catherine Pietanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.